MedPath

BioIntegrate

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Early Phase 1:1
Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Early Phase 1
1 (33.3%)

Umbilical Cord Derived Wharton's Jelly for Knee Osteoarthritis

Early Phase 1
Not yet recruiting
Conditions
Osteoarthritis, Knee
First Posted Date
2021-01-22
Last Posted Date
2022-07-21
Lead Sponsor
BioIntegrate
Target Recruit Count
12
Registration Number
NCT04719793

Evaluation of Safety and Efficacy of Wharton's Jelly Compared to Hyaluronic Acid and Saline for Knee Osteoarthritis.

Phase 1
Not yet recruiting
Conditions
Osteoarthritis, Knee
First Posted Date
2021-01-15
Last Posted Date
2022-07-21
Lead Sponsor
BioIntegrate
Target Recruit Count
168
Registration Number
NCT04711304

DualStim Therapy With or Without Umbilical Cord Derived Wharton's Jelly for Erectile Dysfunction

Phase 1
Not yet recruiting
Conditions
Erectile Dysfunction
First Posted Date
2020-06-11
Last Posted Date
2022-07-21
Lead Sponsor
BioIntegrate
Target Recruit Count
60
Registration Number
NCT04424394

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.